Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research Units
Research output
Search by expertise, name or affiliation
Combination therapy with GLP-1 receptor agonist and SGLT2 inhibitor
Ralph A. DeFronzo
Department of Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
93
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Combination therapy with GLP-1 receptor agonist and SGLT2 inhibitor'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Glucagon Like Peptide 1
75%
Combination Therapy
75%
Patient with Type 2 Diabetes
50%
Glucagon Like Peptide 1 Receptor Agonist
50%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Time
50%
Inpatient
50%
Glucagon
25%
Creatinine Blood Level
25%
Kidney Disease
25%
End Stage Renal Disease
25%
Hemoglobin A1c
25%
Drug
25%
Electric Potential
25%
Antidiabetic Agent
25%
Medicine and Dentistry
Glucagon Like Peptide 1
75%
Combination Therapy
75%
Cardiovascular System
50%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Glucagon-Like Peptide-1 Agonist
50%
Antidiabetic Agent
25%
Hemoglobin A1c
25%
Maturity Onset Diabetes of the Young
25%
Nephropathy
25%
Glucagon
25%
End Stage Renal Disease
25%
Drug
25%
Chemotherapeutic Agent
25%
Combined Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon-Like Peptide-1
75%
Combination Therapy
50%
Sodium Glucose Cotransporter 2 Inhibitor
50%
Glucagon Like Peptide 1 Receptor Agonist
50%
Anti-Inflammatory Drug
50%
Non Insulin Dependent Diabetes Mellitus
25%
Kidney Disease
25%
End Stage Renal Disease
25%
Drug
25%
Glucagon
25%
Antidiabetic Agent
25%
Hemoglobin A1c
25%
Macroalbuminuria
25%
Neuroscience
Glucagon-Like Peptide-1
100%
Anti-Inflammatory
25%
Diabetes Mellitus
25%
Glucagon
25%
Hemoglobin A1c
25%
Glucagon-Like Peptide-1 Receptor Agonist
25%
Biochemistry, Genetics and Molecular Biology
Time
50%
Electric Potential
25%
Glucagon
25%
Receptor Agonists
25%
Creatinine Blood Level
25%